疫苗信任量表:测量与理解疫苗信任的混合方法研究
作者开发了疫苗信任量表(VTG),并在美国对3026名18岁及以上成年人开展调查,依据VTG聚合评分将受访者分为低、中、高疫苗信任水平,并招募65名受访者进行深度访谈或焦点小组。多变量回归发现,VTG测量的较高疫苗信任水平与对医疗服务提供者的信任及对政府的信任密切相关;定性分析为疫苗信任水平补充了多元的情境因素。
要点
- VTG量表在美国3026名18岁及以上成年人中施测,并据此划分低、中、高疫苗信任水平。
- VTG测量的较高疫苗信任与对医疗服务提供者的信任和对政府的信任密切相关。
- 大学或更高学位者、民主党人及55岁及以上人群相比黑人或非裔美国人及在医疗系统中经历歧视者更可能对疫苗有较高信任。
核心结论
- 影响个体疫苗信任的潜在因素多样,因此信任类别和人口学特征不能作为单一标识使用。
- 评估疫苗信任为促进个体层面疫苗接受度的参与工作提供了基础性洞见。
- 作者提出了VTG的使用建议、对未来研究与实践的启示以及建立疫苗信心的潜在策略。
研究设计与样本
- VTG量表基于既往及范围综述性问卷研究开发,并在美国对3026名18岁及以上成年人施测。
- 依据VTG构建的聚合评分系统,将调查应答者按疫苗信任水平分为低、中、高。
- 招募65名受访者参加通过电话或视频会议进行的深度访谈或焦点小组。
- 使用VTG量表的组成部分形成疫苗信任的概念性定义。
主要发现
- 多变量回归发现,VTG测量的较高疫苗信任水平与对医疗服务提供者的信任和对政府的信任密切相关。
- 大学或更高学位者、民主党人及55岁及以上人群相比黑人或非裔美国人及在医疗系统中经历歧视者更可能对疫苗有较高信任。
- 定性分析使作者能够为所总结的疫苗信任水平补充多元的情境因素。
临床怎么用
- 这些混合方法发现提示了对未来研究与实践的启示。
- 作者提供了用于建立疫苗信心并促进COVID-19及其他疫苗接 uptake 的潜在沟通、政策和公共卫生策略思路。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: While trust in vaccination is one factor in the ecosystem that surrounds vaccine decision-making and acceptance, understanding its role may provide insights into effective and tailored approaches to help build individual-level vaccine confidence. The authors developed the Vaccine Trust Gauge (VTG), a scale used to measure trust in vaccines, and conducted mixed methods research to provide an in-depth understanding of the various factors shaping vaccine trust in the United States. MATERIALS AND METHODS: The VTG instrument was developed from previous and scoping research of questionnaires (Larson et al., 2018; Palmedo et al., 2021) and fielded in the US to n = 3026 adults ages ≥18. Based on survey responses, participants were segmented by vaccine trust level (low, medium, or high) through an aggregated scoring system constructed from the VTG. 65 respondents were recruited to participate in in-depth interviews or focus groups conducted by phone or video conference. A conceptual definition of vaccine trust was developed using components of the VTG scale. RESULTS: Multivariate regressions found that higher levels of vaccine trust measured by the VTG are closely associated with trust in healthcare providers and trust in government. College or higher degree, Democrats, and those aged 55+ were more likely to have higher trust in vaccines compared to Black/African Americans, and those experiencing discrimination in the healthcare system. The qualitative analysis allowed the authors to add diverse, contextual elements to the vaccine trust levels summarized here. DISCUSSION: These mixed methods findings suggest future implications for research and practice. Ideas for potential communication, policy, and public health strategies are offered to build vaccine confidence and advance uptake for COVID-19 and other vaccines. CONCLUSIONS: There are diverse underlying factors that influence an individual's trust in vaccines, which means trust categories and demographic characteristics cannot be used as monolithic identifiers. Assessing vaccine trust provides insights into a foundation for engagement to promote individual-level vaccine acceptance. The authors present recommendations for the use of the VTG, future implications for research and practice, and potential strategies to build vaccine confidence.
引用
- Masoud D, Pierz A, Rauh L, et al. Vaccine Trust Gauge: Mixed methods research to measure and understand vaccine trust. Vaccine. 2023. PMID: 37336659. doi:10.1016/j.vaccine.2023.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。